{
  "lung_adenocarcinoma": {
    "tcga_study_code": "LUAD",
    "most_frequent_mutations": {
      "KRAS": {
        "frequency": "32%",
        "subtypes": [
          "G12C: 13%",
          "G12V: 9%",
          "G12D: 7%"
        ]
      },
      "EGFR": {
        "frequency": "14%",
        "subtypes": [
          "L858R: 8%",
          "Exon 19 del: 6%"
        ]
      },
      "TP53": {
        "frequency": "50%",
        "subtypes": [
          "Various missense: 45%",
          "Nonsense: 5%"
        ]
      },
      "STK11": {
        "frequency": "17%",
        "subtypes": [
          "Truncating: 15%"
        ]
      },
      "KEAP1": {
        "frequency": "17%",
        "subtypes": [
          "Various: 17%"
        ]
      },
      "ALK": {
        "frequency": "4%",
        "subtypes": [
          "EML4-ALK: 3%",
          "Other fusions: 1%"
        ]
      },
      "ROS1": {
        "frequency": "2%",
        "subtypes": [
          "CD74-ROS1: 1%",
          "Other fusions: 1%"
        ]
      },
      "BRAF": {
        "frequency": "8%",
        "subtypes": [
          "V600E: 3%",
          "Non-V600: 5%"
        ]
      },
      "MET": {
        "frequency": "4%",
        "subtypes": [
          "Exon 14 skipping: 3%",
          "Amplification: 1%"
        ]
      },
      "RET": {
        "frequency": "1%",
        "subtypes": [
          "KIF5B-RET: 0.5%",
          "CCDC6-RET: 0.5%"
        ]
      }
    },
    "clinical_characteristics": {
      "median_age_at_diagnosis": 66,
      "five_year_survival_rate": "23%",
      "microsatellite_instability_rate": null,
      "tumor_mutational_burden": "High (median: 8.4 mutations/Mb)"
    },
    "therapeutic_targets": [
      {
        "gene": "KRAS",
        "frequency": "32%",
        "actionable_subtypes": [
          "G12C"
        ],
        "clinical_significance": "Targetable"
      },
      {
        "gene": "EGFR",
        "frequency": "14%",
        "actionable_subtypes": [
          "L858R",
          "Exon 19 del",
          "T790M"
        ],
        "clinical_significance": "Targetable"
      },
      {
        "gene": "ALK",
        "frequency": "4%",
        "actionable_subtypes": [
          "EML4-ALK",
          "Other fusions"
        ],
        "clinical_significance": "Targetable"
      },
      {
        "gene": "ROS1",
        "frequency": "2%",
        "actionable_subtypes": [
          "CD74-ROS1",
          "Other fusions"
        ],
        "clinical_significance": "Targetable"
      },
      {
        "gene": "BRAF",
        "frequency": "8%",
        "actionable_subtypes": [
          "V600E",
          "V600K"
        ],
        "clinical_significance": "Targetable"
      }
    ],
    "biomarker_prevalence": {
      "KRAS": "32%",
      "EGFR": "14%",
      "TP53": "50%",
      "STK11": "17%",
      "KEAP1": "17%",
      "ALK": "4%",
      "ROS1": "2%",
      "BRAF": "8%",
      "MET": "4%",
      "RET": "1%"
    },
    "clinical_actionability": {
      "overall_actionability": "5/10 genes targetable",
      "actionable_mutations": {
        "KRAS": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "EGFR": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "TP53": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "STK11": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "KEAP1": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "ALK": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "ROS1": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "BRAF": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "MET": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "RET": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        }
      },
      "precision_medicine_eligibility": 0.5
    },
    "data_sources": "TCGA LUAD (n=585), Lung Cancer Mutation Consortium (n=1007)",
    "verification_date": "2025-07-28T23:11:35.958821",
    "confidence_level": "TCGA_VERIFIED",
    "sample_size": "1592 samples"
  },
  "breast": {
    "tcga_study_code": "BRCA",
    "most_frequent_mutations": {
      "PIK3CA": {
        "frequency": "36%",
        "subtypes": [
          "H1047R: 15%",
          "E545K: 8%",
          "E542K: 6%"
        ]
      },
      "TP53": {
        "frequency": "37%",
        "subtypes": [
          "Various missense: 28%",
          "Nonsense: 9%"
        ]
      },
      "CDH1": {
        "frequency": "13%",
        "subtypes": [
          "Truncating: 10%",
          "Missense: 3%"
        ]
      },
      "GATA3": {
        "frequency": "13%",
        "subtypes": [
          "Frameshift: 8%",
          "Nonsense: 5%"
        ]
      },
      "MAP3K1": {
        "frequency": "9%",
        "subtypes": [
          "Truncating: 7%",
          "Missense: 2%"
        ]
      },
      "HER2": {
        "frequency": "15%",
        "subtypes": [
          "Amplification: 15%"
        ]
      },
      "BRCA1": {
        "frequency": "3%",
        "subtypes": [
          "Germline: 2.5%",
          "Somatic: 0.5%"
        ]
      },
      "BRCA2": {
        "frequency": "4%",
        "subtypes": [
          "Germline: 3.5%",
          "Somatic: 0.5%"
        ]
      }
    },
    "clinical_characteristics": {
      "median_age_at_diagnosis": 58,
      "five_year_survival_rate": "90%",
      "microsatellite_instability_rate": null,
      "tumor_mutational_burden": "Low-Intermediate (median: 1.8 mutations/Mb)"
    },
    "therapeutic_targets": [
      {
        "gene": "PIK3CA",
        "frequency": "36%",
        "actionable_subtypes": [
          "H1047R",
          "E545K",
          "E542K"
        ],
        "clinical_significance": "Targetable"
      },
      {
        "gene": "HER2",
        "frequency": "15%",
        "actionable_subtypes": [
          "Amplification"
        ],
        "clinical_significance": "Targetable"
      },
      {
        "gene": "BRCA1",
        "frequency": "3%",
        "actionable_subtypes": [
          "Germline",
          "Somatic"
        ],
        "clinical_significance": "Targetable"
      },
      {
        "gene": "BRCA2",
        "frequency": "4%",
        "actionable_subtypes": [
          "Germline",
          "Somatic"
        ],
        "clinical_significance": "Targetable"
      }
    ],
    "biomarker_prevalence": {
      "PIK3CA": "36%",
      "TP53": "37%",
      "CDH1": "13%",
      "GATA3": "13%",
      "MAP3K1": "9%",
      "HER2": "15%",
      "BRCA1": "3%",
      "BRCA2": "4%"
    },
    "clinical_actionability": {
      "overall_actionability": "4/8 genes targetable",
      "actionable_mutations": {
        "PIK3CA": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "TP53": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "CDH1": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "GATA3": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "MAP3K1": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "HER2": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "BRCA1": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "BRCA2": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        }
      },
      "precision_medicine_eligibility": 0.5
    },
    "data_sources": "TCGA BRCA (n=1098), METABRIC (n=2509)",
    "verification_date": "2025-07-28T23:11:35.958880",
    "confidence_level": "TCGA_VERIFIED",
    "sample_size": "3607 samples"
  },
  "colorectal": {
    "tcga_study_code": "COADREAD",
    "most_frequent_mutations": {
      "APC": {
        "frequency": "82%",
        "subtypes": [
          "Truncating: 75%",
          "Missense: 7%"
        ]
      },
      "TP53": {
        "frequency": "60%",
        "subtypes": [
          "Missense: 45%",
          "Nonsense: 15%"
        ]
      },
      "KRAS": {
        "frequency": "43%",
        "subtypes": [
          "G12D: 17%",
          "G12V: 13%",
          "G13D: 8%",
          "G12C: 3%"
        ]
      },
      "PIK3CA": {
        "frequency": "18%",
        "subtypes": [
          "H1047R: 8%",
          "E545K: 5%",
          "E542K: 3%"
        ]
      },
      "FBXW7": {
        "frequency": "11%",
        "subtypes": [
          "R465C: 4%",
          "R479Q: 3%",
          "Other: 4%"
        ]
      },
      "SMAD4": {
        "frequency": "10%",
        "subtypes": [
          "Truncating: 8%",
          "Missense: 2%"
        ]
      },
      "BRAF": {
        "frequency": "10%",
        "subtypes": [
          "V600E: 8%",
          "Other: 2%"
        ]
      },
      "NRAS": {
        "frequency": "3%",
        "subtypes": [
          "G12D: 1%",
          "G13R: 1%",
          "Q61K: 1%"
        ]
      }
    },
    "clinical_characteristics": {
      "median_age_at_diagnosis": 68,
      "five_year_survival_rate": "65%",
      "microsatellite_instability_rate": "15%",
      "tumor_mutational_burden": "Low (median: 4.5 mutations/Mb), High if MSI-H (>100 mutations/Mb)"
    },
    "therapeutic_targets": [
      {
        "gene": "KRAS",
        "frequency": "43%",
        "actionable_subtypes": [
          "G12C"
        ],
        "clinical_significance": "Targetable"
      },
      {
        "gene": "PIK3CA",
        "frequency": "18%",
        "actionable_subtypes": [
          "H1047R",
          "E545K",
          "E542K"
        ],
        "clinical_significance": "Targetable"
      },
      {
        "gene": "BRAF",
        "frequency": "10%",
        "actionable_subtypes": [
          "V600E",
          "V600K"
        ],
        "clinical_significance": "Targetable"
      }
    ],
    "biomarker_prevalence": {
      "APC": "82%",
      "TP53": "60%",
      "KRAS": "43%",
      "PIK3CA": "18%",
      "FBXW7": "11%",
      "SMAD4": "10%",
      "BRAF": "10%",
      "NRAS": "3%"
    },
    "clinical_actionability": {
      "overall_actionability": "3/8 genes targetable",
      "actionable_mutations": {
        "APC": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "TP53": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "KRAS": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "PIK3CA": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "FBXW7": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "SMAD4": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "BRAF": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "NRAS": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        }
      },
      "precision_medicine_eligibility": 0.375
    },
    "data_sources": "TCGA COADREAD (n=594), MSK-IMPACT (n=1134)",
    "verification_date": "2025-07-28T23:11:35.958899",
    "confidence_level": "TCGA_VERIFIED",
    "sample_size": "1728 samples"
  },
  "melanoma": {
    "tcga_study_code": "SKCM",
    "most_frequent_mutations": {
      "BRAF": {
        "frequency": "52%",
        "subtypes": [
          "V600E: 40%",
          "V600K: 8%",
          "Other: 4%"
        ]
      },
      "NRAS": {
        "frequency": "28%",
        "subtypes": [
          "Q61R: 12%",
          "Q61K: 8%",
          "Q61L: 5%",
          "G12D: 3%"
        ]
      },
      "NF1": {
        "frequency": "14%",
        "subtypes": [
          "Truncating: 12%",
          "Missense: 2%"
        ]
      },
      "TP53": {
        "frequency": "15%",
        "subtypes": [
          "UV signature: 12%",
          "Other: 3%"
        ]
      },
      "CDKN2A": {
        "frequency": "13%",
        "subtypes": [
          "Deletion: 10%",
          "Point mutations: 3%"
        ]
      },
      "KIT": {
        "frequency": "2%",
        "subtypes": [
          "Exon 11: 1%",
          "Exon 17: 0.5%",
          "Other: 0.5%"
        ]
      },
      "GNA11": {
        "frequency": "1%",
        "subtypes": [
          "Q209P: 0.5%",
          "Q209L: 0.5%"
        ]
      },
      "GNAQ": {
        "frequency": "1%",
        "subtypes": [
          "Q209P: 0.5%",
          "Q209L: 0.5%"
        ]
      }
    },
    "clinical_characteristics": {
      "median_age_at_diagnosis": 61,
      "five_year_survival_rate": "93% (localized), 68% (regional), 27% (distant)",
      "microsatellite_instability_rate": null,
      "tumor_mutational_burden": "Very High (median: 15.8 mutations/Mb)"
    },
    "therapeutic_targets": [
      {
        "gene": "BRAF",
        "frequency": "52%",
        "actionable_subtypes": [
          "V600E",
          "V600K"
        ],
        "clinical_significance": "Targetable"
      }
    ],
    "biomarker_prevalence": {
      "BRAF": "52%",
      "NRAS": "28%",
      "NF1": "14%",
      "TP53": "15%",
      "CDKN2A": "13%",
      "KIT": "2%",
      "GNA11": "1%",
      "GNAQ": "1%"
    },
    "clinical_actionability": {
      "overall_actionability": "1/8 genes targetable",
      "actionable_mutations": {
        "BRAF": {
          "actionability_level": "High",
          "fda_approved_therapies": true,
          "nccn_recommended": true
        },
        "NRAS": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "NF1": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "TP53": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "CDKN2A": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "KIT": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "GNA11": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        },
        "GNAQ": {
          "actionability_level": "Research",
          "fda_approved_therapies": false,
          "nccn_recommended": false
        }
      },
      "precision_medicine_eligibility": 0.125
    },
    "data_sources": "TCGA SKCM (n=448), International Melanoma Consortium",
    "verification_date": "2025-07-28T23:11:35.958915",
    "confidence_level": "TCGA_VERIFIED",
    "sample_size": "448 samples"
  }
}